RIL
BIO icon

Rothschild Investment LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Rothschild Investment LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.51K Buy
9
+6
+200% +$1.73K ﹤0.01% 2442
2025
Q4 		$909 Buy
3
+1
+50% +$312 ﹤0.01% 2712
2025
Q3 		$561 Buy
2
+1
+100% +$272 ﹤0.01% 2794
2025
Q2 		$241 Sell
1
-5
-83% -$1.18K ﹤0.01% 2903
2025
Q1 		$1.46K Sell
6
-24
-80% -$7.22K ﹤0.01% 2103
2024
Q4 		$9.86K Buy
30
+1
+3% +$339 ﹤0.01% 1147
2024
Q3 		$9.7K Hold
29
– – ﹤0.01% 1144
2024
Q2 		$7.92K Buy
29
+24
+480% +$6.98K ﹤0.01% 1139
2024
Q1 		$1.73K Buy
5
+2
+67% +$658 ﹤0.01% 1225
2023
Q4 		$969 Buy
+3
New +$940 ﹤0.01% 1196

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return